Regenerative therapy by fusion of medicine and engineering: First-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: A report of the Symposium of Regenerative Medicine for Patients.

Authors:
Okano T; Sawa Y; Barber E; Umezawa A.

Journal:
Regen Ther

Publication Year: 2015

DOI:
10.1016/j.reth.2015.07.002

PMCID:
PMC6581764

PMID:
31245453

Journal Information

Journal Title: Regen Ther

Detailed journal information not available.

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest Teruo Okano is a founder and member of the board of CellSeed Inc., which has licenses for certain cell sheet-related technologies and patents from Tokyo Women's Medical University. Yoshiki Sawa is receiving research funding from Astellas Pharma Inc., CSL Behring K.K., Edwards Lifesciences Co., Konishi Medical Instruments Co. Ltd., Miyano Medical Instruments Co. Ltd., MSD K.K., Ono Pharmaceutical Co. Ltd. and Terumo Co. The Japanese Society of Regenerative Medicine received funds for the Regenerative Medicine for Patients Symposium from the 2nd Regenerative Medicine Expo & Conference Japan, Acute Support Co. Ltd., Asahi Kasei Co., Astellas Pharma Inc., Biotherapy Institute of Japan, CellSeed Inc., CSL Behring K.K., Cyfuse Biomedical K.K., Cytori Therapeutics Inc., D Value Service GK., Dai Nippon Printing Co. Ltd., Dai-Dan Co. Ltd., Edwards Lifesciences Co., Forum for Innovative Regenerative Medicine, Fujifilm Co., Fujimori Kogyo Co. Ltd., Hamaguchi Lab., Healios K.K., Hitachi, Ltd., Horiba, Ltd., iHeart Japan Co., Ikeda Scientific Co. Ltd., iPS Academia Japan, Inc., IS Technology Japan, Inc., Japan Tissue Engineering Co. Ltd., JCR Pharmaceuticals Co. Ltd., Kaneka Co., Kiwa Laboratory Animals Co. Ltd., Konishi Medical Instruments Co. Ltd., Kowa Co. Ltd., Life Science Institute, Inc., Lonza Japan Ltd., MC Co. Ltd. Medinet Co. Ltd., Menicon Co. Ltd., Mitsui Sumitomo Insurance Co. Ltd., Miyano Medical Instruments Co. Ltd., MSD K.K., Nihon Kohden Co., Ono Pharmaceutical Co. Ltd., Oriental Motor Co. Ltd., Panasonic Healthcare Co. Ltd., PMT Co., Regience K.K., Rohto Pharmaceutical Co. Ltd., Sekisui Seikei Co. Ltd., Shibuya Kogyo Co. Ltd., Shimadzu Co., Shin Nippon Biomedical Laboratories, Ltd., Sompo Japan Nipponkoa Insurance Inc., Sony Co., Sumitomo Dainippon Pharma Co. Ltd., Taisho Toyama Pharmaceutical Co. Ltd., Technos Yashima Co. Ltd., Tella, Inc., Terumo Co., Toyo Seikan Group Holdings, Ltd., Veritas Co. and Yashima Pure Chemicals Co. Ltd."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025